Premier Path Wealth Partners LLC Grows Position in Colgate-Palmolive (NYSE:CL)

Premier Path Wealth Partners LLC raised its position in Colgate-Palmolive (NYSE:CL) by 11.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,240 shares of the company’s stock after purchasing an additional 332 shares during the quarter. Premier Path Wealth Partners LLC’s holdings in Colgate-Palmolive were worth $295,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of CL. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $42,000. Capital Performance Advisors LLP purchased a new stake in Colgate-Palmolive during the 3rd quarter worth about $53,000. Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $64,000. True Wealth Design LLC increased its holdings in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after acquiring an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC raised its position in shares of Colgate-Palmolive by 93.4% during the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after acquiring an additional 368 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. Stifel Nicolaus cut their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday. Barclays decreased their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday. TD Cowen reduced their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Finally, JPMorgan Chase & Co. dropped their price target on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $101.11.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $88.79 on Monday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The company has a market cap of $72.55 billion, a P/E ratio of 25.44, a price-to-earnings-growth ratio of 3.01 and a beta of 0.44. The business has a fifty day moving average of $92.20 and a two-hundred day moving average of $97.75.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.